Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
17,764,587
-
Share change
-
+17,755,180
-
Total reported value
-
$299,695,801
-
Put/Call ratio
-
30%
-
Price per share
-
$16.87
-
Number of holders
-
96
-
Value change
-
+$299,537,804
-
Number of buys
-
95
Institutional Holders of ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA) as of Q2 2017
As of 30 Jun 2017,
ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,764,587 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, GREAT POINT PARTNERS LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Balyasny Asset Management LLC, MILLENNIUM MANAGEMENT LLC, DEERFIELD MANAGEMENT CO, and NORTHERN TRUST CORP.
This page lists
96
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.